Ampicillin sodium

Phase 3Small molecule

UUniversity of Southern California

Ampicillin sodium is one of 8 small molecule programs targeting Chorioamnionitis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ChorioamnionitisActive, not recruiting

ChorioamnionitisPhase 3

Active, not recruiting

Competition

Competitive Landscape

11 competitors in Chorioamnionitis

#DrugCompanyPhaseTrials

Garamycin

SSchering-Plough

Approved

1 2

E-Mycin

AAzurity Pharmaceuticals

Phase 3

1 3

Viramune

Boehringer Ingelheim

Phase 3

1 4

Flagyl

DDePuy Orthopaedics

Phase 3

1 5

Cysteine Hydrochloride

Novartis

Phase 2

1 6

Unasyn

SStanford University

Phase 3

1 7

Ampicillin sodium

UUniversity of Southern California

Phase 3

1 8

Ampicillin/gentamicin

SStanford University

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Chorioamnionitis1 trial

Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 3·NCT00021671·3,720 enrolled

Prospective1 trial

Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients

Completed·UUniversity of Southern California·N/A·NCT00002052

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Ampicillin sodium. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ampicillin sodium compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ampicillin sodium. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Southern California company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: UUniversity of Southern California

Ampicillin sodium

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Chorioamnionitis1 trial

Prospective1 trial

References

Drug Info

Quick Facts

Related News